Correlation Between BioXcel Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioXcel Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioXcel Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioXcel Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on BioXcel Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioXcel Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioXcel Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for BioXcel Therapeutics and X4 Pharmaceuticals
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between BioXcel and XFOR is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding BioXcel Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and BioXcel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioXcel Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of BioXcel Therapeutics i.e., BioXcel Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioXcel Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days BioXcel Therapeutics is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, BioXcel Therapeutics is 2.47 times less risky than X4 Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 50.00 in X4 Pharmaceuticals on August 28, 2024 and sell it today you would lose (16.00) from holding X4 Pharmaceuticals or give up 32.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioXcel Therapeutics vs. X4 Pharmaceuticals
Performance |
| Timeline |
| BioXcel Therapeutics |
| X4 Pharmaceuticals |
BioXcel Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioXcel Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite BioXcel Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioXcel Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |